top of page

Questions and Answers

Public·30 members
Carter White
Carter White

Page 19


Section 340B(a)(5)(B) of the Public Health Service Act prohibits covered entities from reselling or otherwise transferring a 340B covered outpatient drug to a person who is not a patient of the entity. In determining whether an individual qualifies to receive 340B drugs, HRSA believes that it is appropriate to take into account the realities of the COVID-19 pandemic. A covered entity in this public health emergency should continue to ensure it has policies and procedures in place to address the proper dispensing of 340B drugs and it must continue to keep auditable records. During this time, an abbreviated health record may be adequate for purposes of the 340B Program. The record should identify the patient, record the medical evaluation (including any testing, diagnosis or clinical impressions) and the treatment provided or prescribed. For purposes of 340B Program eligibility, the record may be a single form or note page. It is the recorded information that creates a record. For example, under these circumstances the patient may be without insurance cards or identity papers and providers may not have access to documented medical histories. In the current public health emergency, HRSA believes that self-reporting of identity, condition, and history are adequate for purposes of 340B recordkeeping requirements.




Page 19



Below are some general frequently asked questions (FAQs) related to COVID-19. If you have a question related to COVID-19 that we do not cover on this page or in the FAQs below, please contact the 340B Prime Vendor Program at 1-888-340-2787 or apexusanswers@340bpvp.com.


HRSA is unable to waive the disproportionate share adjustment percentage requirements that are set in the 340B statute for certain hospitals seeking to participate as 340B covered entities. Stakeholders are encouraged to review the content on this webpage for certain flexibilities during this time.


To the extent a covered entity has a specific concern about 340B eligibility of a new site, the covered entity should contact the 340B Prime Vendor Program (1-888-340-2787 or apexusanswers@340bpvp.com) and we will evaluate each circumstance on a case-by-case basis. In addition, please review the content on this webpage for certain flexibilities during this time.


At this time, HRSA is unable to waive 340B statutory requirements, specifically the provision related to reselling or otherwise transfer the drug to a person who is not a patient of the entity, pursuant to section 340B(a)(5)(B) of the Public Health Service Act. However, please review the content on this webpage for certain flexibilities during this time related to recordkeeping.


The Department of Health is working with many other state, federal, and local agencies to quickly and equitably distribute COVID-19 vaccine to all New Jersey communities. It is the goal of the Department of Health to make safe and effective COVID-19 vaccination available to all who live, work, and/or are educated in New Jersey.This page and the resources available here will continue to evolve as that effort moves forward.


The United States Residency Certification Program will temporarily accept a signed copy of the base return (for example, page 2 of Form 1040, page 6 of Form 1120, page 5 of Form 1065, etc.) in order to process the Form 8802. The base return will be kept as part of the Form 8802 application and will not be forwarded for processing. The base return will be used to process the Form 8802, rather than requiring the taxpayer to submit a copy of their full return. By filing a signed copy of the base return with your Form 8802, you are attesting that you have previously filed the income tax return with the IRS as shown on the signed copy. This temporary deviation is effective April 4, 2022 and will continue for a pilot period of two years, after which, a determination will be made whether this deviation will be made permanent.


The Centers for Disease Control and Prevention (CDC) created "COVID-19 Community Levels" to help us understand how COVID-19 is impacting where we live and what prevention steps we need to take. Learn more about COVID-19 Community Levels at CDC's COVID-19 by County page.


This page provides information about quarantine, isolation, and self-monitoring for individuals who have been diagnosed with COVID-19 or individuals who have been in close contact with a person who was diagnosed with COVID-19.


Translation of pages on Covid-19 website is performed by Google Translate, a third party service which Alameda County has no control over. The service provides automated computer translations that are only an approximation of the websites' original content. 041b061a72


About

Welcome to the group! You can connect with other members, ge...

Members

bottom of page